Open access
81
Views
6
CrossRef citations to date
0
Altmetric
Original Research
The role of galenic innovation in improving treatment compliance and persistence: three case studies
York Zoellner1 Hamburg University of Applied Sciences, Hamburg, GermanyCorrespondence[email protected]
, Maria-Magdalena Balp2 Novartis Pharma AG, Basel, Switzerland
& Andrea Gili Marco2 Novartis Pharma AG, Basel, Switzerland
Pages 109-116
|
Published online: 04 Aug 2011
Reprints and Permissions
Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.
To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.
For more information please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.